We are live on ! Find out more
NEPH icon

Nephros
NEPH

18 hedge funds and large institutions have $3.95M invested in Nephros in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

246% more capital invested

Capital invested by funds: $1.14M → $3.95M (+$2.81M)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 17 → 18 (+1)

0.5% more ownership

Funds ownership: 41.55% → 42.05% (+0.5%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
7
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$35.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$31.5K
3
VF
Virtu Financial
New York
+$24.2K
4
EP
Elkhorn Partners
Nebraska
+$23.1K
5
UBS Group
UBS Group
Switzerland
+$16K

Top Sellers

Rank Fund Capital Flow
1
CPA
Cowen Prime Advisors
New York
-$65K
2
BA
Bard Associates
Illinois
-$16.4K
3
Morgan Stanley
Morgan Stanley
New York
-$4.19K
4
TCWM
Total Clarity Wealth Management
Illinois
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$3.33M +$3.33K +2,354 +0.1%
BA
2
Bard Associates
Illinois
$229K -$16.4K -11,630 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$134K +$35.5K +25,105 +20%
HighTower Advisors
4
HighTower Advisors
Illinois
$51K – – –
EP
5
Elkhorn Partners
Nebraska
$46K +$23.1K +16,341 +48%
William Blair & Company
6
William Blair & Company
Illinois
$33K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$20K +$31.5K +22,300 New
VF
8
Virtu Financial
New York
$16K +$24.2K +17,089 New
Morgan Stanley
9
Morgan Stanley
New York
$14K -$4.19K -2,962 -16%
State Street
10
State Street
Massachusetts
$14K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$13K +$6.97K +4,932 +53%
Citadel Advisors
12
Citadel Advisors
Florida
$12K +$1.4K +992 +8%
UBS Group
13
UBS Group
Switzerland
$11K +$16K +11,348 +2,157%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$10K – – –
TSS
15
Two Sigma Securities
New York
$9K +$14.4K +10,160 New
BlackRock
16
BlackRock
New York
$4K – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$4K – – –
CPA
18
Cowen Prime Advisors
New York
– -$65K -42,500 Closed
TCWM
19
Total Clarity Wealth Management
Illinois
– -$3K -1,657 Closed
Wells Fargo
20
Wells Fargo
California
– +$4 +3 +5%

NEPH Hedge Fund Activity: Q3 2022 in Review

18 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2022, worth a combined $3.95M — up 246% from $1.14M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NEPH positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $35.5K. The largest seller was Cowen Prime Advisors, exiting entirely with an estimated $65K sold.

  • 18 institutional investors held Nephros (NEPH) as of Q3 2022, up from 17 in Q2 2022.
  • Funds reported $3.95M of Nephros stock for Q3 2022, up 246% quarter-over-quarter.
  • 3 funds opened new Nephros positions in Q3 2022 and 2 closed out, a net change of +1 holder.
  • The largest Nephros buyer in Q3 2022 was Vanguard Group, an estimated $35.5K added.
  • The largest Nephros seller in Q3 2022 was Cowen Prime Advisors, an estimated $65K sold.

Based on aggregated 13F filings for Q3 2022.